Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks ...

On Friday, Dyne Therapeutics, Inc. DYN revealed new data from its ongoing Phase 1/2 ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type 1 (DM1).Dyne plans to begin a global Registrational Expansion Cohort with the potential to support a submission for U.S. Accelerated Approval based on biomarker and functional data in H1 2026.Also Read: Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular DystrophyDyne reported efficacy data from adult DM1 pa ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

In Brief Axios reports that Meta is eliminating its biggest DEI efforts, effective immediately, including ones that focused on hiring a diverse workforce, training, and sourcing supplies from diverse-owned companies. Its DEI department will also be eliminated.  In a memo leaked to the outlet, Meta said it was making these changes because the “legal and policy landscape surrounding diversity, equity, and inclusion efforts in the United States is changing.”  Meta is not alone: Microsoft and Zoom have rolled ...

EverQuote, Inc. (EVER) shares are trading at a premium to the Zacks Multiline Insurance industry. Its price-to-book value of 5.69X is higher than the industry average of 2.3X.EverQuote, an online insurance marketplace, has a market capitalization of $669 million. The average volume of shares traded in the last three months was 0.5 million. Image Source: Zacks Investment ResearchShares of other insurers that provide car insurance, such as Lemonade (LMND) , The Allstate Corporations (ALL) and The Progressive ...

DICK’S Sporting Goods Inc. (DKS) has been showing strong momentum, hovering close to its 52-week high of $239.30. The stock, closing at $233.50 on Wednesday, remains just 2.4% below that peak. Moreover, the stock is currently trading above its 200-day and 50-day moving averages of $209.35 and $211.66, respectively, highlighting a potential upward trend. Image Source: Zacks Investment Research DICK’S stock has seen a remarkable 74% rise in the past year, outpacing the industry's growth of 11.8%. The company’ ...

FormFactor’s (FORM) shares have lost 26.1% in the trailing six months, underperforming the broader Zacks Computer and Technology sector’s return of 3.7% and the Zacks Electronics- Semiconductors industry’s appreciation of 15.7%.FORM shares have lagged industry peers like Marvell Technology (MRVL) , which have surged 63.8% over the same time frame.FormFactor's share price decline can be attributed to expected declines in demand for foundry and logic probe cards, which contributed to a sequential revenue decl ...

On Thursday, Intellia Therapeutics Inc NTLA outlined its strategic priorities for 2025, emphasizing the acceleration of late-stage programs for NTLA-2002 and nex-z.These therapies target hereditary angioedema (HAE) and transthyretin (ATTR) amyloidosis, respectively.Intellia prioritized NTLA-2002 and nex-z while discontinuing the NTLA-3001 program and other early-stage initiatives.The reorganization will result in a 27% workforce reduction and a projected $8 million restructuring charge in early 2025.Intelli ...

NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of Florida on behalf of all persons or entities who purchased or otherwise acquired Micron Technology, Inc. (“Micron Technology” or the “Company”) (NASDAQ: MU) securities between September 28, 2023 and December 18, 2024, inclusive (the “Class Period”). The Complaint alleges that Defendants made false and/or mislead ...

New York, NY, Jan. 10, 2025 (GLOBE NEWSWIRE) --  Spartan Capital Securities, LLC, a premier investment banking firm, is pleased to announce the successful completion of two private placements for Lipella Pharmaceuticals Inc. (Nasdaq: LIPO). Spartan Capital Securities, LLC acted as the sole placement agent in these private offerings of Series B non-voting convertible preferred stock of Lipella Pharmaceuticals Inc., raising an aggregate total of $875,500 through the transactions. The private placements were s ...